Scarica l'app Stockscreener
9.02
0.78%
0.07
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AVTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$8.95
Aprire:
$9.6
Volume 24 ore:
176.00K
Relative Volume:
1.03
Capitalizzazione di mercato:
$118.63M
Reddito:
$1.93M
Utile/perdita netta:
$-7.96M
Rapporto P/E:
-0.00255
EPS:
-3530.8178
Flusso di cassa netto:
$-36.78M
1 W Prestazione:
+1.01%
1M Prestazione:
+87.92%
6M Prestazione:
+22.72%
1 anno Prestazione:
-3.01%
Intervallo 1D:
$8.8032
$9.80
Intervallo di 1 settimana:
$8.29
$9.88
Portata 52W:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Nome
Avalo Therapeutics Inc
Settore
Industria
Telefono
410-522-8707
Indirizzo
1500 LIBERTY RIDGE DRIVE, WAYNE
Confronta AVTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
9.02 | 117.71M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-25 | Iniziato | Jefferies | Buy |
| 2025-03-25 | Iniziato | Stifel | Buy |
| 2025-02-28 | Iniziato | Piper Sandler | Overweight |
| 2025-02-21 | Iniziato | Wedbush | Outperform |
| 2024-12-19 | Iniziato | BTIG Research | Buy |
| 2024-10-24 | Iniziato | H.C. Wainwright | Neutral |
| 2024-04-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Avalo Therapeutics Inc Borsa (AVTX) Ultime notizie
Avalo Therapeutics Inc. stock outlook for YEARShort Setup & Real-Time Volume Triggers - Newser
News impact scoring models applied to Avalo Therapeutics Inc.July 2025 Weekly Recap & Community Supported Trade Ideas - Newser
Avalo Therapeutics Inc. stock momentum explainedCPI Data & Stock Portfolio Risk Management - Newser
Developing predictive dashboards with Avalo Therapeutics Inc. dataJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Should you hold or exit Avalo Therapeutics Inc. nowWeekly Stock Analysis & Short-Term High Return Ideas - Newser
Quantitative breakdown of Avalo Therapeutics Inc. recent moveSell Signal & Verified Stock Trade Ideas - Newser
How to forecast Avalo Therapeutics Inc. trends using time seriesPortfolio Value Report & Stepwise Swing Trade Plans - Newser
How to track smart money flows in Avalo Therapeutics Inc.Weekly Trade Review & Daily Chart Pattern Signals - Newser
Using RSI to spot recovery in Avalo Therapeutics Inc.Weekly Stock Report & Short-Term High Return Ideas - Newser
Buy Signal for Avalo Therapeutics Inc. Stock Key Technical Indicators to WatchJuly 2025 WrapUp & Fast Gain Swing Alerts - Newser
Chart based exit strategy for Avalo Therapeutics Inc.July 2025 Trade Ideas & Smart Money Movement Alerts - Newser
Avalo Therapeutics Initiated with Overweight Rating by Cantor Fitzgerald - AInvest
Can Avalo Therapeutics Inc. recover in the next quarterWeekly Trend Summary & Target Return Focused Picks - Newser
Avalo Therapeutics Gains as Cantor Fitzgerald Initiates Coverage with Bullish View on Lead Asset AVTX-009. - AInvest
Avalo stock gains after Cantor bullish view (AVTX:NASDAQ) - Seeking Alpha
Cantor Fitzgerald initiates Avalo Therapeutics stock with Overweight rating - Investing.com
Cantor Fitzgerald Initiates Avalo Therapeutics at Overweight - MarketScreener
Should you wait for a breakout in Avalo Therapeutics Inc.Forecast Cut & Free Technical Pattern Based Buy Signals - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - Defense World
Is Avalo Therapeutics Inc. reversing from oversold territoryEarnings Summary Report & Growth Oriented Trade Recommendations - Newser
Avalo Therapeutics Reports Q2 2025 Financial Results - MSN
Avalo Therapeutics Inc.’s Beta Climbs After Market VolatilityEarnings Trend Report & Weekly Market Pulse Updates - sundaytimes.kr
What institutions are buying Avalo Therapeutics Inc. stock nowJuly 2025 Sentiment & Weekly Breakout Stock Alerts - Newser
Avalo Therapeutics: Oppenheimer Maintains Buy Rating with $35 Price Target - AInvest
Why Avalo Therapeutics Inc. stock attracts strong analyst attentionIntraday Signal Forecast for Fast Traders - Newser
Custom strategy builders for tracking Avalo Therapeutics Inc.Trade Plan With Low Risk High Return - Newser
Avalo Therapeutics Inc. stock chart pattern explainedFree Capital Preserving Trade Plan Templates - Newser
Avalo Therapeutics (AVTX) up more than 100% since Jul 15 - AInvest
Avalo Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Avalo Therapeutics Inc. forming a reversal patternFree Buy Signal Based on Chart Analysis - Newser
Will a bounce in Avalo Therapeutics Inc. offer an exitMarket Timing Strategy with Technical Filters - Newser
Avalo Therapeutics Inc Azioni (AVTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):